Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: The German trial CAO/ARO/AIO-94

Colorectal Disease

Volumn 5, Issue 5, 2003, Pages 406-415

  Sauer, Rolf ^a   Fietkau, R ^b   Wittekind, C ^c   Rodel C ^a   Martus, P ^d   Hohenberger, W ^a   Tschmelitsch, J ^g   Sabitzer, H ^h   Karstens, J H ^e   Becker, H ^f   Hess, C ^f   Raab, R ^e  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^h GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Neoadjuvant adjuvant radiochemotherapy; Phase III trial; Rectal cancer

Indexed keywords

FLUOROURACIL;

ADULT; ADVANCED CANCER; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; ERYTHEMA; EXCISION; FEMALE; HEART INFARCTION; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PELVIS LYMPH NODE; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; STANDARDIZATION; SURGICAL TECHNIQUE; SURVIVAL RATE; WOUND HEALING IMPAIRMENT;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 10744232150     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00509.x     Document Type: Article

References (38)

1. Douglass HO, Moertel CG, Mayer RJ et al. Survival after postoperative combination treatment of rectal cancer. New Engl J Med 1986; 315: 1294-9.
2. Gastrointestinal Tumor Study Group (GITSG). Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992; 10: 549-57.
3. Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. New Enngl J Med 1991; 324: 709-15.
4. O'Connell MJ, Martenson JA, Wieand HS et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. New Engl J Med 1994; 331: 502-7.
5. Tveit KM, Guldvog I, Hagen S et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil gainst surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997; 84: 1130-5.
6. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 1990; 264: 1444-50.
7. Junginger T, Hossfeld DK, Sauer R, Hermanek P. Adjuvante Therapie bei Kolon- und Rektumkarzinom. Dt Ärztebl 1999; 96: A698-700.
8. Enker WE. Total mesorectal excision - the new golden standard of surgery for rectal cancer. Ann Med 1997; 29: 127-33.
9. Minsky BD, Cohen AM, Kemeny N et al. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992; 10: 79-84.
10. Rödel C, Grabenbauer GG, Schick CH et al. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol 2000; 176: 161-7.
11. Videtic GM, Fisher BJ, Perera FE et al. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 319-24.
12. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. New Engl J Med 1997; 336: 980-7.
13. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
14. Marijnen CAM, Nagtegaal ID, Kranenbarg EK et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976-84.
15. Minsky BD. Adjuvant therapy for rectal cancer - a good first step [letter]. Nov Engl J Med 1997; 14: 1016-7.
16. Hermanek P, Wiebelt H, Staimmer D et al. Prognostic factors of rectum carcinoma. Experience of the German Multicenter Study SGCRC. Tumori 1995; 81: 60-4.
17. Hohenberger W. (1996) The effect of specialization or organization in rectal cancer surgery. In Rectal Cancer Surgery (eds. Soreide O and Norstein J), pp. 353-63. Springer, Berlin.
18. Hermanek P. (1998) Qualität der Chirurgie aus der Sicht des Pathologen. In Rektumkarzinom: das Konzept der Totalen Mesorektalen Exzision. (eds. Büchler MW, Heald RJ, Maurer CA and Ulrich B), pp. 212-9. Karger, Basel.
19. Hermanek P. (2000) What can the pathologist tell the surgeon about rectal cancer resection. In Challenges in Colorectal Cancer (ed. Scholefield JH), pp. 81-90. Blackwell, Oxford.
20. Aaronson NK, Ahmedzai S, Bermann B et al. The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life-instument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365.
21. Koller M, Kußmann J, Lorenz W, Rothmund M. Die Messung der Lebensqualität in der chirurgischen Tumornachsorge. Chirurg 1994; 65: 333-9.
22. Grann A, Minsky BD, Cohen AM. Preliminary results of preoperative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 1997; 40: 515-22.
23. Maghfoor I, Wilkes J, Kuvshinoff B et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer [Abstract]. Proc Am Soc Clin Oncol 1997; 16: 274.
24. Rouanet P, Fabre JM, Dubois JB. Conservative surgery for low rectal carcinoma after high-dose radiation. Ann Surg 1995; 221: 67-73.
25. Wagman R, Minsky BD, Cohen AM et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: Long tern follow-up. Int J Radiat Oncol Biol Phys 1998; 42: 51-7.
26. Påhlman L. Neoadjuvant and adjuvant radio- and radiochemotherapy of rectal carcinomas. Int J Colorectal Dis 2000; 15: 1-8.
27. Rödel C, Fietkau R, Grabenbauer GG et al. Akuttoxizität der simultanen Radiochemotherapic des Rektumkarzinoms. Strahlenther Onkol 1997; 173: 414-20.
28. Minsky BD. Radiation Therapy Oncology Group. Phase III intergroup randomized study of preoperative vs postoperative combined 5-FU/CF and radiotherapy for resectable rectal adenocarcinoma. Protocol RTOG-9401.
29. Hyams DM, Mamounas EP, Petrelli N et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of NSABP R-03. Dis Colon Rectum 1997; 40: 131-9.
30. Sauer R, Fietkau R, Wittekind C et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer a progress report of a phase-III randomized trial. Strahlenther Onkol 2001; 177: 173-81.
31. Nicholls RJ, Mason AY, Morson BC et al. The clinical staging of rectal cancer. Br J Surg 1982; 69: 404-9.
32. Lupo L, Angelleli G, Pannarale O et al. Improved accuracy of computed tomography in local staging of rectal cancer using water enema. Int J Colorectal Dis 1996; 11: 60-4.
33. Adams DR, Blatchford GJ, Lin KM et al. Use of preoperative ultrasound staging for treatment of rectal cancer. Dis Colon Rectum 1999; 42: 159-66.
34. Hünerbein M, Schlag PM. Three-dimensional endosonography for staging of rectal cancer. Ann Surg 1997; 225: 432-8.
35. Minsky BD, Cohen AM, Kemeny N et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992; 10: 1218-24.
36. Cedermark B, Johansson H, Rutquist LE et al. The Stockholm I trial of preoperative short term radiotherapy in operable recatl cancer: a prospective randomized trial. Cancer 1995; 75: 2269-75.
37. Holm T, Rutquist LE, Johansson H, Cedermark B. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy causes and risk factors. Br J Surg 1996; 83: 964-8.
38. Kapiteijn E, Kranenbarg EK, Steup WH et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch Colorectal Cancer Group. Eur J Surg 1999; 165: 410-20.